Trial Information
Exercise in Breast Cancer Survivors: Analysis of Angiogenic Profile
Inclusion Criteria:
- > 18 years of age and < 65 years of age
- Female
- BMI > 25
- Weight < 350 pounds
- English as a primary language
- Postmenopausal
- Invasive ER-positive cancer on biopsy and subsequent definitive surgical therapy
- Received and Completed standard of care adjuvant therapy (Concurrent endocrine
therapy acceptable)
- 6-12 months after completion of therapy (excluding adjuvant endocrine therapy) at
time of randomization
Exclusion Criteria:
- Recurrent breast cancer
- DCIS only (no invasive component)
- Taking a Beta Blocker or Verapamil
- Pregnant
- Wheelchair bound
- Unable to ambulate independently
- Concurrent uncontrolled medical or psychiatric disorder
- Open wound
- Stage IV breast cancer
- Progression of disease
- Bilateral mastectomies
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
Outcome Measure:
Number of participants that complete the study as a measure of feasibility of an exercise intervention in obese breast cancer survivors.
Outcome Description:
Number of participants that enroll in the study and actually complete the study
Outcome Time Frame:
12 months
Safety Issue:
Yes
Principal Investigator
Natale Sheehan, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Mississippi Health Care
Authority:
United States: Institutional Review Board
Study ID:
2011-0121
NCT ID:
NCT01582685
Start Date:
April 2012
Completion Date:
April 2013
Related Keywords:
- Breast Cancer
- Obesity
- Breast Cancer
- Obesity
- Exercise
- Angiogenesis
- Breast Neoplasms
- Obesity
Name | Location |
University of Mississippi Health Care |
Jackson, Mississippi 39216 |